The mRNA therapeutics market offers key opportunities in developing vaccines and treatments for chronic and infectious diseases, driven by successful clinical trials and increased government and ...
A team led by Neil King, a biochemistry professor at the University of Washington School of Medicine, is now exploring a new ...
An mRNA cancer vaccine carries its own immune booster and lights up when it starts working, showing treatment success in mice ...
Alternative splicing exhibits lineage-specific variability, with mammals and birds reaching the highest levels despite conserved intron-rich architectures, while unicellular eukaryotes and prokaryotes ...
Since launching in 2008, the MIT Global Seed Funds (GSF) program has awarded roughly $30 million to more than 1,300 ...
With support from the National Institutes of Health, the COBRE Center for RNA Biology in Health and Disease will create a ...
By tracing when variations in the human genome first appeared, researchers have found that advances in cognitive abilities ...
Molecular biologists have long believed that the beginning of a gene launched the process of transcription—the process by ...
Communicating the clever thinking of scientists who win the Nobels is a rewarding exercise. But lately, it has also become ...
Getting a coronavirus vaccine from manufacturing sites to some parts of the world with rural populations and unreliable electricity supply will be an immense challenge, given the need to store some ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback